These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 30515559)

  • 1. Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma.
    Napieralska A; Brąclik I; Radwan M; Mandera M; Blamek S
    Childs Nerv Syst; 2019 Feb; 35(2):267-275. PubMed ID: 30515559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
    Allen JC; Donahue B; DaRosso R; Nirenberg A
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy?
    Burcu A; Nazan Ç; Özgür Ö; Serra K; Mehmet K; Serap A; Bengü D; Canan V; Haldun Ö; Savaş K; Tuncer T; Taner A; Yeşim E; Ömer K; Yavuz A
    Childs Nerv Syst; 2018 Sep; 34(9):1657-1662. PubMed ID: 29868932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
    Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
    J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
    Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M
    Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of medulloblastoma and ependymoma in infants: a single-institution long-term retrospective report.
    Massimino M; Gandola L; Cefalo G; Lasio G; Riva D; Fossati-Bellani F; Gianni MC; Luksch R; Tesoro-Tess JD; Lombardi F
    Childs Nerv Syst; 2000 Jan; 16(1):15-20. PubMed ID: 10672424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
    Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes After Reirradiation for Recurrent Pediatric Intracranial Ependymoma.
    Tsang DS; Burghen E; Klimo P; Boop FA; Ellison DW; Merchant TE
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):507-515. PubMed ID: 29229328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of surgery and reirradiation for recurrent ependymoma.
    Merchant TE; Boop FA; Kun LE; Sanford RA
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):87-97. PubMed ID: 18406885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
    Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of radiotherapy duration is associated with inferior overall survival in patients with pediatric medulloblastoma and central nervous system primitive neuroectodermal tumors.
    Baliga S; Bajaj BVM; Kabarriti R; Grassberger C; Patteson B; Yeap B; Fox JL; Garg MK; Yock TI
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28558. PubMed ID: 32710698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of radiosurgery in the management of recurrent and residual medulloblastoma.
    Patrice SJ; Tarbell NJ; Goumnerova LC; Shrieve DC; Black PM; Loeffler JS
    Pediatr Neurosurg; 1995; 22(4):197-203. PubMed ID: 7619720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boost Gamma Knife surgery during multimodality management of adult medulloblastoma.
    Germanwala AV; Mai JC; Tomycz ND; Niranjan A; Flickinger JC; Kondziolka D; Lunsford LD
    J Neurosurg; 2008 Feb; 108(2):204-9. PubMed ID: 18240913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-irradiation of recurrent anaplastic ependymoma using radiosurgery or fractionated stereotactic radiotherapy.
    Murai T; Sato K; Iwabuchi M; Manabe Y; Ogino H; Iwata H; Tatewaki K; Yokota N; Ohta S; Shibamoto Y
    Jpn J Radiol; 2016 Mar; 34(3):211-8. PubMed ID: 26682738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study.
    Prados MD; Edwards MS; Chang SM; Russo C; Davis R; Rabbitt J; Page M; Lamborn K; Wara WM
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):279-85. PubMed ID: 10030250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation.
    Saran FH; Driever PH; Thilmann C; Mose S; Wilson P; Sharpe G; Adamietz IA; Böttcher HD
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):959-67. PubMed ID: 9869216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
    Allen J; Donahue B; Mehta M; Miller DC; Rorke LB; Jakacki R; Robertson P; Sposto R; Holmes E; Vezina G; Muraszko K; Puccetti D; Prados M; Chan KW
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1006-11. PubMed ID: 19356859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
    Massimino M; Gandola L; Collini P; Seregni E; Marchianò A; Serra A; Pignoli E; Spreafico F; Pallotti F; Terenziani M; Biassoni V; Bombardieri E; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):404-10. PubMed ID: 17601681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
    Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
    Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.